Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:acquiredBy |
gptkb:Roche
|
| gptkbp:acquisitionYear |
1994
|
| gptkbp:foundedIn |
gptkb:Mexico_City
|
| gptkbp:foundedYear |
1944
|
| gptkbp:founder |
gptkb:Russell_Marker
|
| gptkbp:headquartersLocation |
gptkb:Palo_Alto,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Syntex
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableAchievement |
development of norethindrone
pioneering steroid chemistry |
| gptkbp:notableEmployee |
gptkb:Carl_Djerassi
gptkb:George_Rosenkranz gptkb:Alejandro_Zaffaroni |
| gptkbp:notableProduct |
steroids
oral contraceptives |
| gptkbp:bfsParent |
gptkb:Russell_Marker
|
| gptkbp:bfsLayer |
5
|